Accès gratuit
| Numéro |
Med Sci (Paris)
Volume 38, Numéro 8-9, Août-Septembre 2022
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 746 - 478 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2022116 | |
| Publié en ligne | 12 septembre 2022 | |
- McGuire MJ, Ishii M. Leptin dysfunction and Alzheimer’s disease: evidence from cellular, animal, and human studies. Cell Mol Neurobiol 2016 ; 36 : 203–217. [CrossRef] [PubMed] [Google Scholar]
- Chakrabarti S, Khemka VK, Banerjee A, et al. Metabolic Risk Factors of Sporadic Alzheimer’s Disease: Implications in the Pathology. Pathogenesis and Treatment. Aging Dis 2015 ; 6 : 282–299. [CrossRef] [Google Scholar]
- Khan S, Barve KH, Kumar MS. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease. Curr Neuropharmacol 2020; 18 : 1106–25. [CrossRef] [PubMed] [Google Scholar]
- Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol 2021; 12 : 706978. [CrossRef] [PubMed] [Google Scholar]
- Lloret A, Monllor P, Esteve D, et al. Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate. Front Neurosci 2019 ; 13 : 508. [CrossRef] [PubMed] [Google Scholar]
- Zhao S, Kusminski CM, Elmquist JK, et al. Leptin: Less Is More. Diabetes 2020; 69 : 823–9. [CrossRef] [PubMed] [Google Scholar]
- Izquierdo AG, Crujeiras AB, Casanueva FF, et al. Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?. Nutrients 2019 ; 11 : 2704. [CrossRef] [Google Scholar]
- Van Doorn C, Macht VA, Grillo CA, et al. Leptin resistance and hippocampal behavioral deficits. Physiology & Behavior 2017 ; 176 : 207–213. [CrossRef] [PubMed] [Google Scholar]
- Bonda DJ, Stone JG, Torres SL, et al. Dysregulation of Leptin Signaling in Alzheimer Disease: Evidence for Neuronal Leptin Resistance. J Neurochem 2014 ; 128 : 162–172. [CrossRef] [PubMed] [Google Scholar]
- Flores-Dorantes MT, Díaz-López YE, Gutiérrez-Aguilar R. Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases. Front Neurosci 2020; 14 : 863. [CrossRef] [PubMed] [Google Scholar]
- Niedowicz DM, Reeves VL, Platt TL, et al. Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia. Acta Neuropathol Commun 2014 ; 2 : 64. [CrossRef] [PubMed] [Google Scholar]
- Fuchsberger T, Martínez-Bellver S, Giraldo E, et al. Aβ Induces Excitotoxicity Mediated by APC/C-Cdh1 Depletion That Can Be Prevented by Glutaminase Inhibition Promoting Neuronal Survival. Sci Rep 2016 ; 6 : 31158. [CrossRef] [PubMed] [Google Scholar]
- Dietrich MO, Spuch C, Antequera D, et al. Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging 2008 ; 29 : 902–912. [CrossRef] [PubMed] [Google Scholar]
- Andreoli MF, Donato J, Cakir I, et al. Leptin resensitisation: a reversion of leptin-resistant states. J Endocrinol 2019 ; 241 : R81–R96. [CrossRef] [PubMed] [Google Scholar]
- Greco M, De Santo M, Comandè A, et al. Leptin-Activity Modulators and Their Potential Pharmaceutical Applications. Biomolecules 2021; 11 : 1045. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.